Abridge closes $300M in series E funding, hits $5.3B valuation

Advertisement

Abridge, which provides ambient listening technology for clinical documentation to more than 150 health systems, has raised $300 million to bring its valuation to $5.3 billion.

The series E funding round led by venture capital firm Andreessen Horowitz will allow Abridge to build new products, including software to help with medical billing.

“Every medical conversation is rich with the signals our healthcare system depends on. Abridge activates those signals in the background, silently handling the complexity so clinicians can focus on the human moments that matter,” said Abridge co-founder and CEO Shiv Rao, MD, in a June 24 news release. “We reduce the burden, restore time, and help make care about the people at the heart of it all.”

Abridge’s technology generates clinical notes after medical visits at some of the largest health systems in the country, including Oakland, Calif.-based Kaiser Permanente, Pittsburgh-based UPMC and Sacramento, Calif.-based Sutter Health.

The company says it will support more than 50 million medical conversations in 2025, serving 55 specialities and 28 languages. The technology reduces burnout by up to 60-70%, while over 90% of clinicians continue using it once they start, Abridge said.

Advertisement

Next Up in Innovation

Advertisement